Tower Research Capital LLC (Trc) Allakos Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Allakos Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,042 shares of ALLK stock, worth $970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,042

Previous 15,294 73.57%

Holding current value

$970

Previous $15,000 86.67%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.92 $6,076 - $10,351	-11,252 Reduced 73.57%	4,042 $2,000
Q2 2024 Aug 13, 2024	BUY	$1.0 - $1.45 $11,866 - $17,205	11,866 Added 346.15%	15,294 $15,000
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $6,521 - $20,652	-6,394 Reduced 65.1%	3,428 $4,000
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.18 $8,815 - $16,297	-5,125 Reduced 34.29%	9,822 $26,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $27,641 - $72,022	12,977 Added 658.73%	14,947 $33,000
Q2 2023 Aug 14, 2023	SELL	$3.6 - $5.25 $53,193 - $77,574	-14,776 Reduced 88.24%	1,970 $8,000
Q1 2023 May 09, 2023	SELL	$4.3 - $8.27 $30,706 - $59,056	-7,141 Reduced 29.89%	16,746 $75,000
Q4 2022 Feb 10, 2023	BUY	$5.66 - $8.42 $1,154 - $1,717	204 Added 0.86%	23,887 $201,000
Q3 2022 Nov 10, 2022	BUY	$3.02 - $6.12 $43,001 - $87,142	14,239 Added 150.77%	23,683 $145,000
Q2 2022 Aug 15, 2022	BUY	$2.6 - $6.14 $21,434 - $50,618	8,244 Added 687.0%	9,444 $30,000
Q1 2022 May 12, 2022	SELL	$5.08 - $9.81 $40,218 - $77,665	-7,917 Reduced 86.84%	1,200 $7,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $64,407 - $842,867	7,533 Added 475.57%	9,117 $89,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $299,844 - $432,664	-3,918 Reduced 71.21%	1,584 $167,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $308,783 - $412,699	3,617 Added 191.88%	5,502 $470,000
Q1 2021 May 17, 2021	BUY	$109.73 - $153.66 $89,868 - $125,847	819 Added 76.83%	1,885 $216,000
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1,352 - $2,591	17 Added 1.62%	1,066 $149,000
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $258,744 - $354,406	-3,895 Reduced 78.78%	1,049 $85,000
Q2 2020 Aug 13, 2020	BUY	$44.04 - $80.69 $217,733 - $398,931	4,944 New	4,944 $355,000
Q4 2019 Feb 07, 2020	SELL	$66.49 - $137.73 $35,239 - $72,996	-530 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$31.0 - $89.73 $16,430 - $47,556	530 New	530 $42,000
Q2 2019 Aug 13, 2019	SELL	$36.0 - $44.73 $30,060 - $37,349	-835 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$33.79 - $51.99 $9,866 - $15,181	-292 Reduced 25.91%	835 $34,000
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $19,522 - $38,717	618 Added 121.41%	1,127 $59,000
Q3 2018 Nov 13, 2018	BUY	$31.25 - $47.64 $15,906 - $24,248	509 New	509 $23,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Allakos Inc. Transaction History